Posted by Michael Wonder on 23 Sep 2018
FDA proposes stiff fines for failing to report clinical trials
20 September 2018 - Pharmaceutical companies could face penalties of up to US$10,000 per day.
The US FDA is proposing heavy fines for pharmaceutical companies that fail to report clinical-trial results online.
In a 20 September draft guidance statement, the FDA said that failure to register trials or submit results to the government database ClinicalTrials.gov could result in fines of up to US$10,000 per day.
